The investment-grade notes are due 2029 and 2034

Davis Polk advised the joint book-running managers and representatives of the several underwriters, in connection with the SEC-registered offering by Cardinal Health, Inc. of $650 million aggregate principal amount of its 5.125% notes due 2029 and $500 million aggregate principal amount of its 5.450% notes due 2034.

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. It has operations in more than 30 countries and approximately 48,000 employees globally.

The Davis Polk capital markets team included partner John B. Meade, counsel Jennifer Ying Lan and associate Joyce Kim. Partner Mario J. Verdolini and associate Betsy Johnson provided tax advice. All members of the Davis Polk team are based in the New York office.